Concordia Healthcare Corp. Announces Financial and Operational Results for its Second Quarter, Ended June 30, 2014
CNW Group - Wed Aug 13, 4:00PM CDT
Concordia Healthcare Corp. ("Concordia" or the "Company"
Concordia Healthcare Corp. announces first patients enrolled in Phase 2 clinical trial using Photodynamic Therapy with PHOTOFRIN(R) for patients with mesothelioma
CNW Group - Mon Aug 11, 6:00AM CDT
Concordia Healthcare Corp. ("Concordia"
Concordia Healthcare Corp. initiates Phase 3 bile duct cancer trial using photodynamic therapy with PHOTOFRIN®
PR Newswire - Tue Aug 05, 6:00AM CDT
Thomas Jefferson University Hospital is first site opened, more sites scheduled in August
Concordia Healthcare Corp. to host second quarter 2014 results conference call
CNW Group - Thu Jul 31, 9:30AM CDT
Concordia Healthcare Corp. ("Concordia"
Concordia Healthcare Corp. Reports Results of Annual General and Special Meeting of Shareholders
CNW Group - Fri Jun 27, 2:46PM CDT
Concordia Healthcare Corp. ("Concordia"
Concordia Healthcare to Present at Bloom Burton & Co. Healthcare Investor Conference
CNW Group - Thu Jun 12, 1:00PM CDT
Concordia Healthcare Corp. (TSX: CXR) (OTCQX: CHEHF), today announced that Mark Thompson, Chief Executive Officer, will present at the 2014 Bloom Burton & Co. Healthcare Investor Conference in Toronto, Ontario. Concordia's presentation will take place on Wednesday, June 18, 2014, at 11:00 a.m. ET.
Concordia Healthcare Announces Fiscal 2013 Results (May 2013 - December 2013)
PR Newswire - Mon Mar 31, 6:00AM CDT
Company's board approves an annualized US$0.30 dividend -
FDA Approves Optiguide® DCYL700 Fiber Optic Diffuser Series flexible fiber
PR Newswire - Wed Mar 26, 7:00AM CDT
Concordia Healthcare Corp. ("Concordia" TSX:CXR) announced today that its subsidiary Pinnacle Biologics, Inc. ("Pinnacle"
Concordia Healthcare Corp. to Host Fiscal 2013 Year-End Results Conference Call
CNW Group - Mon Mar 24, 3:00PM CDT
Concordia Healthcare Corp. ("Concordia"
Concordia Healthcare Announces Agreement to Acquire Donnatal®
PR Newswire - Thu Mar 20, 6:30AM CDT
Concordia Healthcare Corp. (Concordia or the Company) (TSX: CXR) (OTCQX: CHEHF), announced today that it has entered into a definitive agreement to acquire Donnatal®, an adjunctive therapy in the treatment of irritable bowel syndrome ("IBS"
IIROC Trade Resumption - Concordia Healthcare Corp.
Newsfile Corp - Wed Feb 19, 7:22AM CST
Trading resumes in:
IIROC Trade Halt - Concordia Healthcare Corp.
Newsfile Corp - Tue Feb 18, 2:57PM CST
The following issues have been halted by IIROC:
Concordia Healthcare Corp. begins trading on OTCQX® in U.S.
CNW Group - Thu Jan 30, 8:02AM CST
Announcement follows recent listing on Toronto Stock Exchange